Volume 18, Number 5—May 2012
Dispatch
Hepatitis E Virus Infection among Solid Organ Transplant Recipients, the Netherlands
Suzan D. Pas, Rob A. de Man, Claudia Mulders, Aggie H.M.M. Balk, Peter T.W. van Hal, Willem Weimar, Marion P.G. Koopmans, Albert D.M.E. Osterhaus, and Annemiek A. van der Eijk
Table 1
Overview of HEV infections among SOT recipients, the Netherlands, 2000–2011*
| SOT group | No. recipients | HEV infections, no. (%) |
|
|---|---|---|---|
| Confirmed | Chronic | ||
| HTX | 259 | 5 (1.9) | 5 (1.9) |
| LungTX | 53 | 1 (1.9) | 1 (1.9) |
| LTX | 300 | 3 (1.0) | 3 (1.0) |
| NTX | 574 | 1 (0.2) | 1 (0.2) |
| Multiple SOT† | 14 | 2 (14.3) | 1 (7.1) |
| Total | 1,200 | 12 (1.0) | 11 (0.9) |
*HEV, hepatitis E virus; SOT, solid organ transplant; HTX, heart transplant; lungTX, lung transplant; LTX, liver transplant; NTX, kidney transplant.
†9 NTX–LTX, 4 NTX–HTX, and 1 NTX–lungTx.
Page created: April 17, 2012
Page updated: April 17, 2012
Page reviewed: April 17, 2012
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.